Soy pinitol acts partly as an insulin sensitizer or insulin mediator in 3T3-L1 preadipocytes
© Springer-Verlag 2007
Published: 27 November 2007
The blood glucose-lowering property of pinitol is mediated via the insulin signaling pathway. This study was carried out to evaluate the effects of soy pinitol on adipogenesis in a 3T3-L1 cell line; 3T3-L1 preadipocytes were treated with pinitol (0–1 mM) together with insulin for 9 days. The regulation of lipid metabolism was assessed by oil-red-O staining of intracellular lipids and real-time PCR of adipogenesis-related factors. The inhibition of cell proliferation was estimated by MTT assay. Pinitol treatment did not inhibit lipid accumulation, nor did it affect expression of adipogenesis-related factors, including ADD1, aP2 and FAS, in a dose-dependent manner. Expression of adiponectin, GLUT4, IRS, C/EBPα and PPARγ mRNAs, however, increased in cells treated with 0.5 mM and/or 1 mM pinitol. Pinitol treatment did not affect the inhibition of cell growth and proliferation in a dose-dependent manner. Accordingly, we suggest that pinitol is nontoxic to this cell line, and that it enhances adipogenesis by acting as an insulin sensitizer or insulin mediator via the upregulation of adiponectin, GLUT4, IRS, C/EBPα and PPARγ in 3T3-L1 preadipocytes.
Adipose tissue consists of adipocytes, which store triacylglycerol as a fuel for the body. Excess adipose tissue leads to insulin resistance, thereby increasing the risk of type 2 diabetes and cardiovascular diseases . In many obesity-related studies, the fibroblastic 3T3-L1 preadipocyte line is widely used to investigate the mechanism of preadipocyte proliferation and adipocyte genesis, due to the ability of this cell line to undergo complete differentiation into mature adipocytes, which differentiate according to a program coordinated by adipogenic molecules, including a variety of growth factors, cytokines and hormones [2, 3]. Insulin promotes lipogenesis and inhibits lipolysis when treated with appropriate agents such as dexamethasone and isoutylmethylxanthine (IBMX). The 3T3-L1 preadipocytes change from an extended fibroblast-like morphology to a round morphology with cytoplasmic lipid vesicles made from newly biosynthesized triglycerides .
d-Chiro-inositol (DCI)—recently found in inositol phosphoglycan—is thought to be a mediator of insulin signaling pathways and to be involved in glycosylphosphatidyl-inositol protein anchors . DCI is obtained mostly from dietary pinitol (3-O-methyl-d-chiroinositol), a methylated derivative of DCI. Pinitol is a prominent component of dietary legumes, soy and pine trees . Some reports have reported a hypoglycemic effect of pinitol—it affects glucose uptake via a postreceptor pathway of insulin action in normal, STZ-diabetic rats . Bates et al.  reported that d-pinitol provides a substrate for the phosphatidylinositol-3-kinase (PI3K)-mediated step of insulin signaling, thereby enhancing a very weak insulin signal and action in order to mimic, in part, the PI3K pathway of insulin action. However, it has been also reported that pinitol does not improve the action of insulin in carbohydrate- or fat-metabolism . On the other hand, pinitol has been suggested to possess various biological effects, including anti-inflammatory , cardiovascular disease-preventing , and creatine retention promotion properties . Reaven et al.  reported that dietary pinitol as a supplement may be recommended to help maintain normal metabolic functions.
In the present study, we investigated the effects of pinitol on the regulation of cell differentiation and adipogenesis by using oil-red-O staining, quantitative real-time PCR, and an MTT assay in 3T3-L1 preadipocytes.
Material and methods
Cell culture and treatments
To determine the state of adipose differentiation by visual inspection, the cells were washed with phosphate-buffered saline (PBS) twice, fixed with 10% formalin at room temperature for 10 min, and stained with 0.5% oil-red-O (Sigma) for 1 h. After staining, the cultures were rinsed several times with 70% ethanol. Pictures were taken using an Olympus (Tokyo, Japan) microscope.
Quantitative real-time reverse transcriptase-polymerase chain reaction
Primer sequences used for real-time PCR. GLUT4 Glucose transporter 4, IRS insulin receptor substrate, PPARγ peroxisome proliferators-activated receptor γ, C/EBPα CCAAT/enhancer-binding protein α, ADD1 adipocyte determination- and differentiation-dependent factor 1, aP2 adipocyte bindgin protein aP2, FAS fatty acid synthase, GAPDH glyceraldehyde-3-phosphate dehydrogenase
Growth inhibition by pinitol was determined by MTT assay . Before treatment, cells were first grown overnight on a 96 well plate at a density of 1 × 104 cells/well. After 24 h, various concentrations of pinitol (0–1 mM) were applied to the cells in serum-free DMEM, and cells were incubated for an additional 48 h at 37°C. After 48 h of oxidant treatment of cells, the culture medium was aspirated under vacuum, and 200 μl MTT (1 mg/ml) was added and further incubated for 4 h at 37°C. The MTT solution was discarded by aspirating, and the resulting formazan product, which was converted by viable cells, was dissolved in 150 μl dimethylsulfoxide. The absorbance was read by an ELISA plate reader at 540 nm with a 620 nm reference. Cell viability, or the inhibition of cell population growth, is expressed as a percentage of the absorbance seen in untreated control cells.
Statistical analysis was performed using the SPSS 11.5 program package. Data were expressed as mean ± SD. Analysis of variance was performed using ANOVA procedures. Significant differences (P < 0.05) between the means were determined by Duncan’s multiple range tests.
Effect of pinitol on lipid accumulation in 3T3-L1 adipocytes
Effect of pinitol on mRNA expression of adipogenesis-related factors in 3T3-L1 adipocytes
Effect of pinitol on inhibition of cell population growth in 3T3-L1 preadipocytes
Adipogenic capacity is affected by the combined effect of proadipogenic and antiadipogenic hormones and growth factors. Following induction of adipogenesis, preadipocytes upregulate key adipogenic transcription factors including C/EBPα, PPARγ and ADD1/SREBP1c [15–17]. C/EBPα plays a regulatory role in adipocyte differentiation through increases expression during the adipose conversion of 3T3-L1 preadipocytes, and expression of C/EBPα induces the coordinate expression of a group of adipocyte genes (i.e., aP2, GLUT4, IRS) [18, 19]. PPARγ was originally shown to play an important role in adipocyte differentiation, glucose homeostasis and insulin signaling; PPARγ agonists are useful in the treatment of patients with type 2 diabetes, because they stimulate adipogenesis and, at the same time, reduce insulin resistance . Recently, it was reported that PPARγ mRNA expression in the adipose tissue of humans was inversely associated with cardiovascular risk factors, and that there was a significant association between PPARγ polymorphism and coronary artery disease . ADD1/SREBP1c plays a crucial role in fatty acid metabolism and insulin-dependent gene regulation, especially in the regulation of lipogenic gene expression in fat and liver for whole body energy homeostasis [17, 22]. In this study, 0.5 and 1 mM pinitol upregulated the expression of PPARγ and C/EBPα mRNAs without altering the gene expression of ADD1/SREBP1c. Notably, PPARγ agonists or synthetic ligands of PPARγ result in both increased gene expression and increased circulating levels of adiponectin [23, 24]. Our results show that pinitol treatment increase adiponectin gene expression—an adipocytokine shown to possess antidiabetic, antiatherogenic and anti-inflammatory properties . Insulin also increases the expression of adiponectin , and perhaps the insulin-like pinitol affected the upregulation of adiponectin gene in this study.
It is well established that insulin promotes the translocation of the insulin responsive glucose transporter, GLUT4, from the intracellular compartment to the plasma membrane . The binding of insulin to its receptor triggers the phosphorylation of insulin receptor substrate (IRS) proteins. Tyrosine phosphorylated IRS proteins recruit and sequentially activate PI3K , which is one of the key components of the insulin signaling pathway. Hence, there is great interest in glucose transport and PI3K signaling in diabetes mellitus. Pinitol also increased GLUT4 and IRS gene expression, perhaps due to its insulin-mimicking property. Pinitol, however, did not alter the expression of the aP2 and FAS genes, which are related to adipocyte differentiation  and de novo lipogenesis via synthesis of long-chain fatty acids from acetyl-CoA and malonyl-CoA , respectively.
There are currently no known examples of any adverse side effects arising from the use of pinitol at recommended dosage levels [6, 31]. In this study, the results of the MTT assay clearly indicated that pinitol did not inhibit cell population growth of 3T3-L1 preadipocytes (Fig. 4).
In conclusion, this study reports that soy pinitol did not block adipocyte differentiation, proliferation or lipid accumulation in a dose-dependent manner, and that most factors related to adipogenesis and glucose transport were upregulated by pinitol treatment in real-time RT-PCR assays, although there was no alteration in the expression of aP2, ADD1/SREBP1c or FAS mRNA. Accordingly, we suggest that pinitol may improve glucose transport and insulin sensitivity because high-dose pinitol treatment (0.5 and 1 mM) enhanced the expression of adiponectin, GLUT4, IRS, C/EBPα, and PPARγ mRNA, as a putative insulin mediator or insulin sensitizer. These effects are believed to be similar to those of PPARγ agonists; supplementation with dietary pinitol may help in the prevention and therapy of type 2 diabetes.
This work was supported by the Korea Research Foundation grant by the Korean Government (MOEHRD)(R08-2004-000-10499-0) and the second-phase of BK21 (Ministry of Education, Republic of Korea).
- Saltiel AR, Kahn CR (2001) Insulin signaling and the regulation of glucose and lipid metabolism. Nature 414:799–806PubMedView ArticleGoogle Scholar
- Cowherd RM, Lyle RE, McGehee RE Jr (1999) Molecular regulation of adipocyte differentiation. Cell Develop Biol 10:3–10View ArticleGoogle Scholar
- MacDougald OA, Mandrup S (2002) Adipogenesis forces that tip the scales. Trends Endocrinol Metab 13:5–11PubMedView ArticleGoogle Scholar
- Green H, Kehinde O (1974) Sublines of mouse 3T3 cells that accumulate lipid. Cell 1:113–116View ArticleGoogle Scholar
- Holman GD, Kasuga M (1997) From receptor to transporter: insulin signaling to glucose transport. Diabetologia 40:l001–1003View ArticleGoogle Scholar
- Ostlund et al (1996) United States Patent. Patent Number 5,550,166. August 277Google Scholar
- Huang LC, Fonteles MC, Houston DB, Zhang G, Larner J (1993) Chiroinositol deficiency and insulin resistance. III. Acute glycogenic and hypoglycemic effects of two inositol phosphoglycan insulin mediators in normal and streptozotocin-diabetic rats in vivo. Endocrinology 132:652–657PubMedView ArticleGoogle Scholar
- Bates SH, Jones RB, Bailey CJ (2000) Insulin-like effect of pinitol. Br J Pharmacol 130:1944–1948PubMedView ArticleGoogle Scholar
- Campbell WW, Haub MD, Fluckey JD, Ostlund RE Jr, Thyfault JP, Morse-Carrithers H, Hulver MW, Birge ZK (2004) Pinitol supplementation does not affect insulin-mediated glucose metabolism and muscle insulin receptor content and phosphorylation in older human. J Nutr 134:2998–3003PubMedGoogle Scholar
- Singh RK, Pandey BL, Tripathi M, Pandey VB (2001) Anti-inflammatory effect of (+)-pinitol. Firoterapia 72:168–170View ArticleGoogle Scholar
- Kim JI, Kim JC, Kang MJ, Lee MS, Kim JJ, Cha IJ (2005) Effects of pinitol isolated from soybeans on glycemic control and cardiovascular risk factors in patients with type 2 diabetes mellitus: a randomized controlled study. Eur J Clin Nutr 59:456–458PubMedView ArticleGoogle Scholar
- Greenwood M, Kreider RB, RasMussen C, Almada AL, Earnest CP (2001) d-Pinitol augments whole body creatine retention in man. J Exer Physiol 4:41–47Google Scholar
- Reaven G (1995) Pathophysiology of insulin resistance in human disease. Physiol Rev 75:473–486PubMedGoogle Scholar
- Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63PubMedView ArticleGoogle Scholar
- Cao Z, Umek RM, Mcknight SL (1991) Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 5:1538–1552PubMedView ArticleGoogle Scholar
- Zhu Y, Qi C, Korenberg JR, Chen XN, Noya D, Rao MS, Reddy JK (1995) Structural organization of mouse peroxisome proliferators-activated receptor γ (mPPARγ) gene: altenative promoter use and different splicing yield two mPPARγ isoforms. Proc Natl Acad Sci USA 92:7921–7925PubMedView ArticleGoogle Scholar
- Kim JB, Spiegelman BM (1996) ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev 10:1096–1107PubMedView ArticleGoogle Scholar
- Birkenmeier EH, Gwynn B, Howard S, Jerry J, Gordon JI, Landschulz WH, McKnight SL (1989) Tissue-specific expression, developmental regulation and genetic mapping of the gene encoding CCAAT/enhancer binding protein. Genes Dev 3:1146–1156PubMedView ArticleGoogle Scholar
- Christy RJ, Kaestner KH, Gelman DE, Lane MD (1991) CCAAT/enhancer binding proteins gene promoter: binding of nuclear factors during differentiation of 3T3-L1 preadipocytes. Proc Natl Acad Sci USA 88:2593–2597PubMedView ArticleGoogle Scholar
- Kersten S, Desvergne B, Wahli W (2000) Roles of PPARs in health and disease. Nature 405:421–424PubMedView ArticleGoogle Scholar
- Krempler F, Breban D, Oberkofler H, Esterbauer H, Hell E, Paulweber B, Patsch W (2000) Leptin, peroxisome proliferators-activated receptor-γ, and CCAAT/enhancer binding protein α mRNA expression in adipose tissue of humans and their relation to cardiovascular risk factors. Arterioscler Thromb Vasc Biol 20:443–449PubMedGoogle Scholar
- Foretz M, Guichard C, Ferre P, Foufelle F (1999) Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related gene. Proc Natl Acad Sci USA 96:12737–12742PubMedView ArticleGoogle Scholar
- Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matusuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimomura I, Matsuzawa Y (2001) PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50:2094–2099PubMedView ArticleGoogle Scholar
- Sharabi Y, Oron-Herman M, Kamari Y, Avni I, Peleg E, Shabtay Z, Grossman E, Shamiss A (2007) Effect of PPAR-gamma agonist on adiponectin levels in the metabolic syndrome: lessons from the high fructose fed rat model. Am J Hyperten 20:206–210View ArticleGoogle Scholar
- Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, Schelthess T, Engel J, Brownlee M, Scherer PE (2003) Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity. J Biol Chem 278:9073–9085PubMedView ArticleGoogle Scholar
- Scherer PE, Williams S, Fogliani M, Baldini G, Lodish HF (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270:26746–26749PubMedView ArticleGoogle Scholar
- Shepherd PR, Kahn BB (1999) Glucose transporters and insulin action–implications for insulin resistance and diabetes mellitus. New Engl J Med 341:248–257PubMedView ArticleGoogle Scholar
- Czech MP (2002) Fat targets for insulin signaling. Mol Cell 9:695–696PubMedView ArticleGoogle Scholar
- Rosen ED, Scarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegelman BM, Mortensen RM (1999) PPARγ is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 4:611–617PubMedView ArticleGoogle Scholar
- Wakil S (1989) Fatty acid synthase, a proficient multifunctional enzyme. Biochemistry 28:4523–4530PubMedView ArticleGoogle Scholar
- Narayanan C (1987) Pinitol-a new anti-diabetic compound from the leaves of Bougainvillea. Curr Sci 56:76–78Google Scholar